On September 7, 2026, Shenguan Biology Science & Technology Investment Company Limited bought 2.51 million shares of SHENGUAN HLDGS (00829) stock at an average of HKD 0.1662 per share, involving about HKD 416,497.
Prior to the acquisition, the declarant's long position in SHENGUAN HLDGS was 1.65 billion shares, representing 50.95%; following the acquisition, the holding changed to 1.65 billion shares, with the long position ratio rising to 51.03%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.